Menu
Menu
SOPHiA GENETICS is proud to participate in the 50th National Congress of the Mexican Association of Human Genetics (AMGH) and the 9th Latin American Congress of Human Genetics, organized by AMGH and the Red Latinoamericana de Genética Humana.
📅 November 12–14, 2025
📍 Hotel Sheraton Buganvilias, Puerto Vallarta, Jalisco, Mexico
As a global leader in data-driven medicine, we are thrilled to join this milestone event, bringing together experts, researchers, and clinicians from across Latin America.
📍 Visit us at Booth 6
Our team will be on-site to showcase how the SOPHiA DDM™ Platform transforms complex genomic data into actionable insights—empowering healthcare professionals to accelerate discovery, enhance diagnosis, and drive precision medicine forward.
SOPHiA GENETICS is proud to participate in the Congreso Latinoamericano de Patología 2025, taking place in Santiago, Chile.
📍 Visit us at Booth S5
Our team will be on-site to showcase how SOPHiA GENETICS is transforming pathology and laboratory medicine with data-driven insights. Explore our latest innovations across Liquid Biopsy, Solid Tumors, Hematologic Malignancies, and more—empowering clinicians and researchers to advance precision medicine in Latin America.
We look forward to connecting with the pathology community in Santiago and sharing how our technology is shaping the future of healthcare.
Translating NGS Workflows into Real-World Impact in Hemato-Oncology
You are invited to join our networking event on hematologic malignancies during the 2025 Association of Molecular Pathologists Annual Meeting & Expo in Boston, USA.
Connect with peers and leading experts to explore how NGS-based solutions are advancing the investigation of complex variants in hematological malignancies.
During this event, speakers from renowned institutions will share real-world experiences implementing diverse NGS applications, including:
This is your opportunity to learn how peers are overcoming technical hurdles, realizing practical benefits, and applying NGS strategies to make genomic interpretation and decision-making in blood cancers more efficient.
What: Blood Cancer Showcase at AMP
Where: Omni Hotel - Marquee Room
Date: November 12th
Time: 6:30 pm – 8:15pm
Agenda to follow
Reserve your seat to this exclusive event on Wednesday, November 12th starting at 6:30 pm.
We’re excited to be part of the 36th Brazilian Congress of Medical Genetics, joining experts, researchers, and clinicians from Brazil. Our focus this year is on presenting the most recent launch — SOPHiA DDM™ Enhanced Exome Solutions. Visit us at booth #3 to learn how our technology can empower your work in medical genetics.
SOPHiA GENETICS is thrilled to return and join the genomics community at this year’s American Society of Human Genetics (ASHG) Annual Meeting in Boston, Massachusetts.
Visit Booth #1040 to explore the next-generation SOPHiA DDM™ Platform and Alamut™ Visual Plus, and uncover our latest advancements in Enhanced Exome and Whole Genome Sequencing analytics.
Join us and be part of the conversation with our experts, partners, and users as we tackle the challenges of rare and inherited disorder and pharmacogenomic analysis.
Poster Presentation
Wednesday, Oct 15 | 02:30 – 04:30 PM | Exhibit & Poster Hall, Lower Level Board 8008W
Authored and presented by: Adrian Janiszewski
Co-lab Theater Talk
Thursday, Oct 16 | 12:00 – 12:30 pm | Theatre 1, Exhibit & Poster Hall, Lower Level
Simple workflows for complex genomics: A closer look at our latest enhanced exome and whole genome capabilities
Presented by: Guilherme Yamamoto, Head of Genomics and Bioinformatics Innovation, Dasa Brazil
Presented by: Izabela Matyszczak, Technical Product Management Expert, Genomic Research Expert, SOPHiA GENETICS
SOPHiA GENETICS is excited to join this year’s International Society of Liquid Biopsy (ISLB), in Orlando, Florida, where we’ll showcase our latest liquid biopsy applications designed to advance oncology research and tumor mutation profiling.
Visit us at Booth #302 to connect with our team and explore innovative solutions, including MSK-ACCESS® powered with SOPHiA DDM™, to see how we’re helping shape the future of precision medicine.
Showcase Theatre
Sunday, Nov 2 | 10:50 – 11:10 AM | Showcase Theatre
Decentralized Liquid Biopsy Testing Using MSK-ACCESS® with SOPHiA DDM™: Insights from Multi-Cancer Clinical Profiling in OncoHelix
Presented by: Dr. Rehan Mujeeb Faridi, Director of Molecular Diagnostics, OncoHelix
SOPHiA GENETICS is pleased to announce its participation in the upcoming HGSA 2025 Congress, taking place in Sydney, Australia. As a leader in data-driven medicine, we look forward to engaging with the genetics and healthcare community at this prominent event.
We invite all attendees to visit us at Booth #5 to discover the latest innovations in our New Generation SOPHiA DDM™ Platform. Our showcase will highlight significant advancements in exome sequencing, as well as our cutting-edge oncology solutions, including MSK-ACCESS® and MSK-IMPACT®, both powered by SOPHiA DDM™.
Join us to learn how SOPHiA GENETICS is advancing precision medicine through robust, multimodal, and globally applicable solutions.
SOPHiA GENETICS is proud to participate in the 70th Anniversary of the SBG Congress, taking place in Belém, Brazil, in 2025. As a global leader in data-driven medicine, we are thrilled to engage with the genetics and healthcare communities at this landmark event.
📍 Visit us at Booth #5
Our team will be on-site to showcase how SOPHiA GENETICS is transforming complex genomic data into actionable insights—empowering clinicians and researchers worldwide.
Discover the New Generation SOPHiA DDM™ Platform
Explore our most recent innovations in Exome Sequencing, and learn how they are advancing the diagnosis and resolution of complex genetic cases.
Save the date! Corporate Workshop
Date: August 15
Time: 1:00 pm - 2:00 pm
Hangar 2 Room
Title: Unraveling Complex Genetic Disorders via Exome Sequencing
Speakers:
Dra. Ilana Zalcberg Renault, Onco-hematologist, Dasa Genômica
Bruno Piovezan, Subject Matter Expert, SOPHiA GENETICS
SOPHiA GENETICS is excited to attend this year’s Association of Molecular Pathology (AMP) Annual Meeting!
Find us at booth #921 to learn about how we are enabling breakthrough innovations in cancer research.
Wednesday, November 12, 10:00 – 10:50 am | Corporate Workshops | 160C Level 1
Elevating CGP with Agile Solutions: The New MSK-IMPACT® Flex powered with SOPHiA DDM™
Speakers:
Wednesday, November 12, 11:00 – 11:50 am | Corporate Workshops | 160C Level 1
Redefining Precision Oncology with MSK-ACCESS® powered with SOPHiA DDM™
Speakers:
Friday, November 14, 9:15am – 10:15am | Poster number: ST044
Robust RNA profiling using the SOPHiA DDM™ RNAtarget Oncology Solution with FFPE tumor samples
Authored by: Izabela Matyszczak, Slawomir Kubik, Jonathan Bieler, Ewan Smith, Jonathan Lopez, Alexandre Harlé, Christian Pozzorini, Zhenyu Xu
Saturday, November 15, 9:15am – 10:15am | Poster number: ST041
MSK-IMPACT Flex powered with SOPHiA DDM™ enables sample-specific comprehensive genomic profiling through selective analysis of DNA and RNA biomarkers
Authored by: Izabela Matyszczak, Christian Pozzorini, Gregoire André, Tommaso Coletta, Amjad Alkodsi, Frederic Michaud, Yvan Wenger, Elia Magrinelli, Anjali Anjali, Zhenyu Xu
We are thrilled to be back at 15th World Clinical Biomarkers & Companion Diagnostics Summit. Join us and meet our BioPharma team to learn how we help BioPharma companies address challenges throughout the drug development continuum, enhancing efficiency and precision to accelerate the development of better and more effective precision therapeutics.
If you are attending, don’t miss:
Lunch & Learn hosted by SOPHiA GENETICS on Wednesday, September 24th, from 1.10 to 2.10 pm.
Join us for a special lunch session spotlighting the journey of MSK-ACCESS® powered with SOPHiA DDM™ from an in-house solution at Memorial Sloan Kettering Cancer Center (MSK) to a globally scalable, decentralized, best-in-class liquid biopsy platform, through a strategic collaboration with SOPHiA GENETICS.
Talk on Thursday, September 25th, from 11.00 to 11.30 am, in Track A.
“Bridging the Gap: A Hybrid Deployment Model for Scaling Innovation in Oncology”
Jess Lambe, Vice President and Managing Director of BioPharma Business Development, SOPHiA GENETICS
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.